methylprednisolone has been researched along with exenatide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Alejandro, R; Ichii, H; Inverardi, L; Miki, A; Misawa, R; Mita, A; Ricordi, C; Sakuma, Y; Yamamoto, T | 1 |
1 review(s) available for methylprednisolone and exenatide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for methylprednisolone and exenatide
Article | Year |
---|---|
Improved human islet preparations using glucocorticoid and exendin-4.
Topics: Cell Culture Techniques; Cell Survival; Chemokines; Culture Media; Cytokines; Exenatide; Glucose; Humans; Inflammation Mediators; Insulin; Insulin Secretion; Islets of Langerhans; MAP Kinase Signaling System; Methylprednisolone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptides; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Venoms | 2014 |